Pharmacom Biovet Stock Price on September 16, 2024
| PHMB Stock | USD 0.0001 0.00 0.00% |
Below is the normalized historical share price chart for Pharmacom Biovet extending back to June 06, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pharmacom Biovet stands at 0.0001, as last reported on the 25th of November, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day.
If you're considering investing in Pharmacom Stock, it is important to understand the factors that can impact its price. We have found three technical indicators for Pharmacom Biovet, which you can use to evaluate the volatility of the company.
The current year's Total Stockholder Equity is expected to grow to about 61.4 K. The current year's Common Stock is expected to grow to about 40.3 K. Pharmacom Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.0001 | 50 Day MA 0.0001 |
Pharmacom |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PHMB |
Based on monthly moving average Pharmacom Biovet is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharmacom Biovet by adding Pharmacom Biovet to a well-diversified portfolio.
Enterprise Value 1.1 M | Market Capitalization 1.1 M |
Pharmacom Biovet Valuation on September 16, 2024
It is possible to determine the worth of Pharmacom Biovet on a given historical date. On September 16, 2024 Pharmacom was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pharmacom Biovet stock. Still, in general, we apply an absolute valuation method to find Pharmacom Biovet's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pharmacom Biovet where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pharmacom Biovet's related companies.
| Open | High | Low | Close | Volume | |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
09/16/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| Backtest Pharmacom Biovet | | | Pharmacom Biovet History | | | Pharmacom Biovet Valuation | Previous | Next |
Pharmacom Biovet Trading Date Momentum on September 16, 2024
| On September 17 2024 Pharmacom Biovet was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . There was no trading activity during the period 1.0. Lack of trading volume on September 17, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Pharmacom Biovet Fundamentals Correlations and Trends
By evaluating Pharmacom Biovet's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pharmacom Biovet's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pharmacom financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pharmacom Biovet Stock history
Pharmacom Biovet investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pharmacom is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pharmacom Biovet will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pharmacom Biovet stock prices may prove useful in developing a viable investing in Pharmacom Biovet
| Last Reported | Projected for Next Year | ||
| Net Loss | -639.6 K | -671.6 K |
Pharmacom Biovet Stock Technical Analysis
Pharmacom Biovet technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pharmacom Biovet Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Pharmacom Biovet cannot be verified against its exchange. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pharmacom Biovet November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Pharmacom Biovet stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharmacom Biovet shares will generate the highest return on investment. By undertsting and applying Pharmacom Biovet stock market strength indicators, traders can identify Pharmacom Biovet entry and exit signals to maximize returns
Complementary Tools for Pharmacom Stock analysis
When running Pharmacom Biovet's price analysis, check to measure Pharmacom Biovet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacom Biovet is operating at the current time. Most of Pharmacom Biovet's value examination focuses on studying past and present price action to predict the probability of Pharmacom Biovet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacom Biovet's price. Additionally, you may evaluate how the addition of Pharmacom Biovet to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |